Bayer and Kumquat Biosciences, a clinical-stage biotech company established by pioneers in targeting the KRAS pathway, have announced the start of a Phase I clinical trial for KQB548, an investigational inhibitor aimed at treating KRAS G12D-mutated
Under the Ayushman Bharat framework, the Union government has continuously sought to improve the primary to tertiary care continuum. Comprehensive primary care is being ensured through more than 1.79 lakh Ayushman Arogya Mandirs, and infrastructure
Today, Centrix Pharma Solutions, Sai Life Sciences, and Agility Life Sciences announced the formation of an Integrated CMC Partnership aimed at offering innovative biopharma firms comprehensive Chemistry, Manufacturing, and Controls (CMC) services
Alembic Pharmaceuticals Ltd. and Amlan International have jointly declared the launch of MinerTox-Z and MinerTox-A in India. These are the two new feed additive solutions that combat harmful toxins and mai the productivity of poultry farms...
Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, announced the launch of FineCross M3 Coronary Micro-Guide Catheter in India.
Eli Lilly announced a $1 billion investment in Telangana, aimed at expanding contract manufacturing and establishing a new advanced facility in Hyderabad. The move is expected to significantly boost the company’s global medicine supply.
Eli Lilly and Company has revealed a substantial investment in India of up to $1 billion over the next few years to build new contract manufacturing facilities and a new advanced manufacturing and quality hub in Hyderabad. The US pharma company...
Indian pharmaceutical companies are entering global partnerships to produce a generic version of Gilead Sciences’ HIV prevention drug, with public health advocates urging that its launch be prioritized in India to improve patient access
Wockhardt shares surged 7.45% to 1,435 following the publication of positive Phase 3 clinical trial results for its novel antibiotic Miqnaf (nafithromycin)
The results of a statewide review of 3.9 lakh lipid profile tests performed in the previous year have been made public by Metropolis Healthcare. According to the study, there has been a worrying change in the cardiovascular landscape of India
.jpg)
, CDSCO.jpg)